The global Next Generation Sequencing (NGS) Market size was estimated at USD 12,990 million in 2024 and is projected to reach USD 31,910.4 million in 2031 at a CAGR of 13.7 % during the forecast period 2025-2031.
Next Generation Sequencing (NGS) refers to a set of advanced technologies that allow for rapid and high-throughput sequencing of DNA and RNA, enabling researchers to decode genetic material more efficiently and cost-effectively than traditional methods.
Get Free Sample Report: https://www.delvens.com/get-free-sample/next-generation-sequencing-ngs-market
Experts in the Next Generation Sequencing (NGS) Market highlight several key trends driving growth and innovation. Next Generation Sequencing (NGS) is a transformative technology that enables rapid, high-throughput sequencing of DNA and RNA, revolutionizing genomics, clinical diagnostics, and personalized medicine.
It has broad applications across fields like oncology, infectious diseases, and agriculture, allowing for detailed genetic analysis and mutation detection. The market is driven by advances in sequencing technologies that reduce costs, improve accuracy, and expand accessibility, alongside the increasing demand for precision medicine and targeted therapies.
Key trends include the integration of AI for data analysis, the rise of non-invasive liquid biopsy, and a focus on enhancing sequencing accuracy. NGS is expected to continue shaping the future of healthcare by enabling more personalized and effective treatments.
North America to Dominate the Next Generation Sequencing (NGS) Market
- North America led the NGS market with a dominant share of approximately 50%. This growth is driven by the presence of numerous clinical laboratories utilizing NGS for genetic testing services. Additionally, high levels of R&D investment, along with a robust healthcare research framework, are contributing to the development of WGS in the region.
- The Asia Pacific region is anticipated to be the fastest-growing market, fuelled by significant advancements in China and Japan regarding the integration of NGS technologies.
- The UK Next Generation Sequencing market is expected to grow in line with the broader European market, driven by the increasing development of companion diagnostics and the establishment of molecular diagnostic facilities by leading market players.
Top Key Competitors:
- Illumina
- Hoffman-La Roche Ltd.
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies
- PierianDx
- Genomatix GmbH
- DNASTAR, Inc.
- Perkin Elmer, Inc.
- Eurofins GATC Biotech GmbH
- And More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/next-generation-sequencing-ngs-market
Recent Developments
In May 2024, Oxford Nanopore Technologies partnered with Twist Bioscience to introduce a new Pharmacogenomics Beta Programme. This long-read pharmacogenomics solution, intended for research use, aims to deliver clear genetic results through a streamlined, end-to-end workflow, from sample preparation to pharmacogenomics star allele calling.
In September 2023, PacBio unveiled a collaboration with Hamilton, Integra, Revvity, and Tecan to develop fully automated protocols for preparing samples to be sequenced on the Revio and Sequel II and IIe systems.
Next Generation Sequencing (NGS) Market Segmentations:
Based on Technology
- WGS
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
Based on Product
- Platform
Based on Application
- Oncology
- Clinical Investigation
- Reproductive Health
- Metagenomics, Epidemiology & Drug Development
- Agrigenomics & Forensics
Based on End-use
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other Users
The Report helps to identify the opportunities in Global Regions:
- North America (the United States, Canada, and Mexico)
- Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
- South America (Brazil etc.)
- The Middle East and Africa (North Africa and GCC Countries)
Access Full Report: https://www.delvens.com/report/next-generation-sequencing-ngs-market
In addition to the market data for the Next Generation Sequencing (NGS) Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Frequently Asked Questions
- What are the years considered to study Next Generation Sequencing (NGS) Market intelligence report?
- What is the compound annual growth rate (CAGR) of the Next Generation Sequencing (NGS) Market?
- Which region holds the largest market share in Next Generation Sequencing (NGS) Market?
- Which region is the fastest growing in Next Generation Sequencing (NGS) Market?
- Who are the major players in Next Generation Sequencing (NGS) Market?
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
